Ghost Tree Capital, LLC Immuno Gen, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $1.06 Million - $1.49 Million	75,000 Added 75.0%	175,000 $2.78 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $93,663 - $500,788	-24,977 Reduced 19.99%	100,000 $1.89 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $458,665 - $614,886	124,977 New	124,977 $479,000
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $71,400 - $91,125	-7,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $50,250 - $97,125	7,500 New	7,500 $225,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.